Podcasts about antibiotic stewardship

"Ich habe als Notärztin weniger Leben gerettet, als ich es jetzt in der Hygiene tue" sagt unsere Gesprächspartnerin, Professorin Irit Nachtigall. Frau Prof. Nachtigall leitet seit Juni 2024 die Abteilung für Translationale Forschung, Lehre und Kooperation bei Vivantes und hat eine W3-Professur für Infektiologie und Infektionsprävention an der Medical School Berlin inne. Neben leitenden Positionen im Bereich Krankenhaushygiene und Antibiotic Stewardship bei den Helios Kliniken war sie als Anästhesistin und Intensivmedizinerin an der Charité tätig. Ihre Forschungsschwerpunkte liegen in den Bereichen Antibiotic Stewardship und Infektionen durch multiresistente Erreger mit einem besonderen Fokus auf Gender Medicine in der Infektiologie. Sie entwickelte ein Clinical Decision Support System (CDSS) für die Antibiotikatherapie, arbeitet an der Weiterentwicklung der Sepsis-Diagnostik und engagiert sich für Geschlechtergerechtigkeit in der medizinischen Digitalisierung. Gefällt Ihnen der Podcast der Aesculap Akademie? Haben Sie Anregungen? Wen sollten wir unbedingt einmal zum Gespräch einladen? Wir freuen uns über ihr Feedback. Schreiben Sie an podcast@aesculap-akademie.de

ESCMID Global, ESCMID's flagship congress, kicks off this Friday in Vienna. In light of that, Angela Huttner and Thomas Tängdén sit down with ESCMID leadership, President Robert Skov and Immediate-Past President Annelies Zinkernagel in this episode of Communicable. Together they discuss the roles of medical societies like ESCMID in shaping healthcare policy, the importance of scientific communication, and lessons learned from the COVID pandemic. The conversation highlights ESCMID's priorities for the future on addressing antimicrobial resistance, fostering international collaboration and new educational initiatives. The episode also features personal anecdotes about what makes coming together at ESCMID Global so special. Tune in for a comprehensive look at how ESCMID is championing medical progress in infection for a healthier tomorrow.This episode was edited by Kathryn Hostettler and not peer reviewed.ReferencesGlobal impact of US policy changes: The ESCMID perspective. CMI Comms 2025;2(2): 105073.Malani AN, Sharland M, Clancy CJ, Skov R, ESCMID & IDSA Executive Boards. A global call to action to fight antimicrobial resistance: IDSA and ESCMID joint white paper. CMI Comms 2024; 1(2): 105033.Baghdadi JD & Morgan DJ. Diagnostic tests should be assessed for clinical impact. CMI Comms 2024; 1(2): 105010.

Communicable returns to the topic of gender dynamics in medicine in the second half of this special. This round, Angela Huttner wants to hear from the men, CMI Comms editors Marc Bonten, Josh Davis, Navaneeth Narayanan and Thomas Tängdén, about tackling issues like the evolving expectations at home and work, the impact of parental-leave policies, and the systemic biases that continue to shape careers. Personal anecdotes and reflections highlight both the progress made and the hurdles that still exist in striving for true gender equity in the medical profession. Editors Erin McCreary and Annie Joseph of CMI Comms also participate in the discussion, with Annie sharing an interesting follow-up to her story told in part 1.

In dieser Folge berichten wir von der gemeinsamen Jahrestagung der Deutschen Desellschaft für Infektiologie und dem Deutschen Zentrum für Infektionsforschung (DGI / DZIF Meeting), das im Februar in München stattfand. Wir haben mit Wissenschaftler:innen und Kliniker:innen über aktuelle Themen aus der Forschung und Medizin gesprochen. Den Auftakt macht Florian Krammer, Professor für Vakzinologie an der … „Infektiopod #92: News vom DZIF/DGI Meeting“ weiterlesen

In this episode of The Burleson Box, Dr. Dustin Burleson welcomes Dr. Erinne Kennedy, Assistant Dean for Curriculum and Integrated Learning at Kansas City University College of Dental Medicine. Dr. Kennedy shares her fascinating journey into dentistry, which was heavily influenced by her family of dental professionals and her passion for public health. She recounts the pivotal moment when a mentor encouraged her to apply for a dental public health specialty—at Harvard—within a two-week deadline, a decision that shaped the course of her career.Our discussion covers the pressing issue of burnout in the dental profession, with Dr. Kennedy offering valuable insights backed by research. She explains how excessive working hours, lack of adequate recovery time, and administrative burdens contribute to burnout among healthcare professionals. Using a compelling analogy comparing work schedules to endurance training, she illustrates the importance of balancing workload and rest. She also introduces the concept of "resilience confetti," small, joyful activities that help dental professionals maintain well-being and engagement during their workday.Dr. Kennedy and Dr. Burleson explore strategies that dental teams can implement to create healthier work environments, such as rethinking office hours, planning meaningful time off, and fostering a culture that prioritizes both patient care and team well-being. They discuss innovative scheduling models, including the effectiveness of three-day, 12-hour shifts, and how such models can improve job satisfaction and reduce burnout.A significant part of the conversation focuses on the future of preventive dentistry. Dr. Kennedy shares her excitement about advancements in salivary testing, peptides, and microbiome management, predicting that these innovations will reshape how dental professionals approach prevention. She explains how new materials and techniques, such as peptide-based remineralization and nanoparticle technology, could reduce the need for surgical interventions and lead to better long-term patient outcomes.As an educator, Dr. Kennedy highlights the importance of emotional intelligence and leadership training in dental schools. She describes the Thrive program at KCU, a two-day workshop designed to help students develop resilience, goal-setting skills, and emotional maturity. She stresses that fostering a mindset of adaptability and openness to unexpected opportunities is crucial for career growth.Wellness Resources:The Genius of Athletes by Noel Brick Ph. D. and Scott DouglasAtomic Habits by James ClearAntibiotic Stewardship Resources:Association for Dental Safety Antibiotic Stewardship ResourcesAmerican Dental Association Antibiotic Stewardship ResourcesCariology Resources:Carequest Managing Dental CariesCarequest Connect Caries Risk Assessments and Cultural AwarenessCarequest Utilizing Caries Management by Risk Assessment to Deliver Person-Centered Care ***The Burleson Box is brought to you by Stax Payments:Save Big on Transaction Fees: Boost Your Bottom Line with Stax Payments.Did you know that your practice can start saving thousands of dollars on your monthly processing costs with our preferred payments partner, Stax? Simplify your practice operations and provide a quality patient experience. Healthcare practices like yours need a way to accept payments simply and securely. That's where Stax comes in.Stax helps you manage your entire payments experience from within one platform. You can safely accept touch-free payments in-person, online, or over the phone, securely store and manage patient information with layered security and Level 1 PCI compliance.
Take advantage of a simpler, more transparent way to process your payments with competitive flat-rate pricing, provided exclusively through Stax. No additional fees or contracts required!Power your practice and get paid faster with simple, safe and secure payment solutions. Have questions? Schedule time to speak with a dedicated payment consultant to learn more.Click Below to Lear More Today:StaxPayments.com/burleson-seminars*** Go Premium: Members get early access, ad-free episodes, hand-edited transcripts, exclusive study guides, special edition books each quarter, powerpoint and keynote presentations and two tickets to Dustin Burleson's Annual Leadership Retreat.http://www.theburlesonbox.com/sign-up Stay Up to Date: Sign up for The Burleson Report, our weekly newsletter that is delivered each Sunday with timeless insight for life and private practice. Sign up here:http://www.theburlesonreport.com Follow Dustin Burleson, DDS, MBA at:http://www.burlesonseminars.com

03/03/25: Joel Heitkamp is out, and Richland County Commissioners Perry Miller and Nathan Berseth fill in for him. They're joined by Dr. Avish Nagpal from Sanford Health to talk about the measles. Dr. Nagpal practices internal medicine, specializing in infectious disease and travel and tropical medicine. He also serves as associate professor of medicine at the University of North Dakota; adjunct faculty at North Dakota State University; medical director of Infection Prevention and Control; and in a leadership role in Antibiotic Stewardship. (Joel Heitkamp is a talk show host on the Mighty 790 KFGO in Fargo-Moorhead. His award-winning program, “News & Views,” can be heard weekdays from 8 – 11 a.m. Follow Joel on X/Twitter @JoelKFGO.)See omnystudio.com/listener for privacy information.

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-057-H01-PInitial release date: 3/3/2025Expiration date: 3/3/2026Additional CPE details can be found here.

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-057-H01-PInitial release date: 3/3/2025Expiration date: 3/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Several publications have described wondrous therapeutic effects of faecal microbiota transplant (FMT) on Clostridioides difficile infection. Yet the recent randomised trial assessing FMT in US veterans was terminated early for futility. In this episode, hosts Angela Huttner and Marc Bonten delve into the history, application, and complexities of FMT with experts Maria Vehreschild (Frankfurt University Hospital, Germany) and Dimitri Drekonja (Minneapolis Veteran Affairs Care System and University of Minnesota, US), who led the US trial. From the regulatory challenges and trial nuances to important new research, this conversation sheds light on a potentially revolutionary yet controversial treatment. Episode was edited by Kathryn Hostettler and peer-reviewed by Arjana Zerja (Mother Theresa University Hospital Centre, Tirana, Albania).Other mentions:EurFMTEuropean Directorate for the Quality of Medicines & HealthCare. Guide to the quality and safety of tissues and cells for human application. vol. 5th ed. EDQM Council of Europe; 2022. https://freepub.edqm.eu/publications/17/detail LiteratureDrekonja DM et al (2024) Clin Infect Dis, doi: 10.1093/cid/ciae467

This is episode 1 of the series: The Antibiotic Crisis: The Role of Antibiotic StewardshipEpisode 1: Antibiotic resistance is a critical global health issue that threatens the effectiveness of essential treatments. As frontline healthcare providers, nurses play a vital role in promoting antibiotic stewardship, ensuring appropriate use, and preventing the spread of resistance. This podcast episode empowers nurses with essential knowledge and tools to become effective stewards of antibiotics, emphasizing the importance of education, global impact, and successful stewardship strategies. Episode 2: This episode focuses on practical strategies for promoting antibiotic stewardship across clinical settings. It highlights the importance of effective communication, collaboration with interdisciplinary teams, and robust infection prevention measures. The discussion also covers the use of data to monitor antibiotic use, improve outcomes, and the role of stewardship in agriculture. Listeners will gain insights into resources and training to help healthcare professionals champion responsible antibiotic practices. ---Nurses may be able to complete an accredited CE activity featuring content from this podcast and earn CE hours provided from Elite Learning by Colibri Healthcare. For more information, click hereAlready an Elite Member? Login hereLearn more about CE Podcasts from Elite Learning by Colibri HealthcareView Episode TranscriptView this podcast course on Elite LearningSeries:  The Antibiotic Crisis: The Role of Antibiotic Stewardship

This is episode 2 of the series: The Antibiotic Crisis: The Role of Antibiotic StewardshipEpisode 1: Antibiotic resistance is a critical global health issue that threatens the effectiveness of essential treatments. As frontline healthcare providers, nurses play a vital role in promoting antibiotic stewardship, ensuring appropriate use, and preventing the spread of resistance. This podcast episode empowers nurses with essential knowledge and tools to become effective stewards of antibiotics, emphasizing the importance of education, global impact, and successful stewardship strategies. Episode 2: This episode focuses on practical strategies for promoting antibiotic stewardship across clinical settings. It highlights the importance of effective communication, collaboration with interdisciplinary teams, and robust infection prevention measures. The discussion also covers the use of data to monitor antibiotic use, improve outcomes, and the role of stewardship in agriculture. Listeners will gain insights into resources and training to help healthcare professionals champion responsible antibiotic practices. ---Nurses may be able to complete an accredited CE activity featuring content from this podcast and earn CE hours provided from Elite Learning by Colibri Healthcare. For more information, click hereAlready an Elite Member? Login hereLearn more about CE Podcasts from Elite Learning by Colibri HealthcareView Episode TranscriptView this podcast course on Elite LearningSeries:  The Antibiotic Crisis: The Role of Antibiotic Stewardship

Despite being preventable and curable, tuberculosis remains a major global health threat, infecting over 10 million people and claiming more than 1 million lives every year. In this episode of Communicable, hosts Angela Huttner and Navaneeth Narayanan discuss tuberculosis with experts Lorenzo Guglielmetti of Doctors without Borders and Olha Konstantynovska of Kharkiv National University, Ukraine. Key topics include the history, transmission, and pathophysiology of tuberculosis, as well as current diagnostic challenges and treatments for drug-resistant strains. The conversation highlights Lorenzo's work on the endTB project and Olha's experiences managing tuberculosis during the war in Ukraine. Despite advancements in treatment, the episode underscores the urgent need for political will and funding to combat this global health threat.This episode was edited by Kathryn Hostettler and peer reviewed by Dr. Maria Ana de Quadros Flores e Santos of Unidade Local de Saude Santa Maria, Lisbon, Portugal. Abbreviations and terminology used in this episode:MSF: Médecins sans Frontières, or Doctors without Borders (msf.org)FIND: Foundation for Innovative New Diagnostics (www.finddx.org)‘Intoxication symptoms' are synonymous with ‘constitutional symptoms' or ‘B symptoms' of tuberculosis and include fever, night sweats, and unintentional weight loss.  Literature:endTB ProjectAnnual global tuberculosis report by WHO 2024 Dorman SE, et al. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med 2021 doi: 10.1056/NEJMoa2033400Guglielmetti L, et al. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med 2025 doi: 10.1056/NEJMoa2400327

In this, Kent discusses some embarrassing moments in hospital rooms and then dives into antibiotics (and other drugs) for pets. You don't know better than your vet, please don't tell them they need to give you antibiotics without consult. Thanks!

Sexually transmitted infections (STIs) affect millions globally daily, and multidrug-resistant strains are complicating treatment. Hosts Angela Huttner and Josh Davis welcome experts Dr. Teodora Elvira Wi from WHO and Professor Catriona Bradshaw from Monash University to discuss critical issues surrounding ‘super gonorrhoea,' chlamydia, syphilis, Mycoplasma genitalium, and bacterial vaginosis. The episode reviews the latest epidemiology and highlights the need to innovate diagnostics and treatment options, destigmatise STIs, and promote people-centred healthcare strategies to manage and prevent these infections.  This episode was edited by Kathryn Hostettler and peer-reviewed by Dr. Arjana Zerja of Mother Theresa University Hospital Centre, Tirana, Albania.   Literature: Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021. Chris Kenyon et al. on screening impact for gonorrhoea and chlamydia infections in key populations The Lancet HIV 2024.

On this episode of The ICHE Podcast, we dive into research priorities in healthcare-associated infections (HAIs) and antimicrobial stewardship (AS) with experts Robin Jump, Jennie Kwon, Daniel Livorsi, Lona Mody, and Eli Perencevich. The discussion explores the importance of publishing research agendas to stimulate focused research, guide researchers in prioritizing critical topics, and inform funding decisions. By addressing these goals, the panel aims to align research efforts with pressing clinical challenges, foster innovation, and bridge gaps between research and implementation. The guests also discuss the structured methodologies used to draft these research agendas, detailing how key priorities were identified and refined to address the most urgent needs in the field. The panel reviews three recently published agendas in ICHE: A Call to Action: The SHEA Research Agenda to Combat Healthcare-Associated Infections, Research Agenda for Transmission Prevention within the Veterans Health Administration, 2024–2028, and Research Agenda for Antibiotic Stewardship within the Veterans Health Administration, 2024–2028. Key topics include addressing antimicrobial resistance, improving diagnostic tools, and tackling HAIs in vulnerable populations. The conversation further examines the applicability of findings from VA-specific agendas to non-VA healthcare settings, concluding that many insights are broadly relevant. Listeners will gain a clearer understanding of the research landscape and actionable ways to contribute to advancements in patient safety and healthcare quality. For further details, explore the full articles discussed in this episode at Cambridge.org/ICHE.

Rising anti-vaccine sentiment and dissemination of misinformation are threats to public health. In the US, calls to revoke certain public health mandates have been proposed by likely members of the incoming administration, among them vaccination against polio. The fourth instalment of the Nightmare Series is both a cautionary tale and an effort to preserve and share clinical expertise on how to diagnose and manage polio and rubella in a world where, until now, few doctors have had to face these illnesses in the clinical setting. Host Angela Huttner welcomes Professor Emeritus of Infectious Diseases Bernard Hirschel at the University of Geneva and Dr. Kerrigan McCarthy of the Centre for Vaccines and Immunology at South Africa's National Institute for Communicable Diseases (NICD) for that discussion. This episode was edited by Kathryn Hostettler and peer-reviewed by Dr. Barbora Píšová in Antwerp, Belgium. Literature Link-Gelles R et al (2022) MMWR https://www.cdc.gov/mmwr/volumes/71/wr/mm7133e2.htm  Ryerson AB et al (2022) MMWR https://www.cdc.gov/mmwr/volumes/71/wr/mm7144e2.htm  Kasstan B et al (2023) Epidemiol Infect doi: 10.1017/S0950268823001127 NICD (2024) Report: Rubella in South Africa, 2024.https://www.nicd.ac.za/surge-in-rubella-cases-in-south-africa-november-2024/

The last episode of the year carries a special end-of-year message from the CMI Comms editors and replays the very first episode of Communicable aired on 10 May 2024, in which editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global 2024 in Barcelona, providing insights into the trials' designs, results, and implications. The DOTS trial compared two doses of long-acting dalbavancin to standard of care in patients with complicated S. aureus bacteraemia. GAME-CHANGER compared cefiderocol to standard of care for Gram-negative infections. PediCAP compared oral step-down therapy with amoxicillin with or without clavulanic acid at shorter durations to the current WHO-recommended standard of five days of intravenous antibiotic therapy in children with severe pneumonia. Additional results from the MULTICAP and CLEEN trials, the CAMERA-2 follow-on in vitro analysis, and the Burkina Faso Escherichia coli transmission study are also discussed. This episode was peer-reviewed by Dr. Yousra Kherabi (Clinical Trials Research Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA; Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris; and Université Paris Cité, Inserm, IAME, Paris, France).

Matters Microbial #70: Food Safety and Antibiotic Resistance December 18, 2024 Today, Dr. Dr. Erika Ganda, Assistant Professor of Food Animal Microbiomes in the Department of Animal Science at Pennsylvania State University, joins the #QualityQuorum to discuss the varied interests of her research team studying the intersection of animal husbandry, microbiome studies, and the threat of antimicrobial resistance. Host: Mark O. Martin Guest: Erika Ganda Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video that Dr. Quinn and yours truly did for an event at Harvard University about #LuxArt. A video of a #LuxArt event I ran at ASMCUE a few years ago. An overview from the CDC about the One Health concept. The story of “Typhoid Mary.” An overview of rumen microbiology. The glass artwork of Jane Hartman. An article about Salmonella dublin and the impact on the dairy industry. An introduction to strategies of antibiotic resistance. A TED talk about the threat of antibiotic resistance. The concept of low level antibiotics to promote growth in chickens and other animals. A video demonstrating the swift rise of antibiotic resistance using  the MEGAPLATE approach. The accident in Brazil in 2015 releasing metal mining waste leading to increased antibiotic resistance. Evidence that microbial zinc resistance leads to increased antibiotic resistance. An explainer for proper antibiotic use. Dr. Ganda's faculty website. Dr. Ganda's research website Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Send us a textIn this episode, Ben and Daphna speak with Dr. Martin Stocker, head of neonatology and pediatric intensive care at the Children's Hospital of Central Switzerland. Dr. Stocker discusses the challenges of identifying sepsis in neonates and the overuse of antibiotics in this vulnerable population. He emphasizes the importance of balancing the risks of sepsis with the long-term consequences of antibiotic overuse. The conversation explores the role of clinical signs, risk factors, and biomarkers like IL-6, as well as the need for algorithms to guide decision-making. This insightful discussion highlights the complexities of neonatal sepsis management.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Substandard and falsified (SF) antimicrobials are a neglected global health problem and have been implicated as drivers of antimicrobial resistance (AMR). Substandard medicines are authorized medical products that fail to meet either their quality standards or their specifications, whereas falsified medicines are those that deliberately and fraudulently misrepresent their identity, composition or source. Host Angela Huttner is joined by Pernette Bourdillon Esteve, Technical Officer for the World Health Organization's Substandard/falsified Medical Products group, and Ben Cooper, epidemiologist at Oxford University and head of its Drug-Resistant Infection and Disease Dynamics (DRIaDD), to explore the effects of SF antimicrobials on people and AMR.This episode was edited by Kathryn Hostettler and peer-reviewed by Dr. Arjana Zerja of Mother Teresa University Hospital in Tirana, Albania. Literature Cavany S et al.  Nat Commun 14, 6153 (2023). doi: 10.1038/s41467-023-41542-w WHO Global Surveillance and Monitoring System for substandard and falsified medical products (2017). https://www.who.int/publications/i/item/9789241513425 

In this episode, Drs. Erica Stohs, Ryan Stevens, and Jame McCrae join Dr. Megan Klatt to discuss antimicrobial stewardship practices at transitions of care and in the outpatient setting. Hear from the experts on how to establish programs in this space, best practices for data/reporting, and other tips for stewardship intervention. Follow us on Instagram! @breakpointspodcast_sidp References: Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge. 10.1001/jamanetworkopen.2022.11331 From concept to reality: Building an ambulatory antimicrobial stewardship program. 10.1002/jac5.1528 Cracking the code(s): Optimization of encounter-level diagnosis coding to inform outpatient antimicrobial stewardship data modeling. 10.1017/ice.2023.296 Antibiotic Prescribing Variability in a Large Urgent Care Network: A New Target for Outpatient Stewardship. 10.1093/cid/ciz910 DART communication for respiratory illness treatment resources: Dialogue Around Respiratory Illness Treatment (DART) – iMTR (uwimtr.org)

Antibiotikaresistenzen: Vom richtigen Umgang mit Antibiotika bis Therapien der Zukunft

Dr Keith Hamilton joins Ethics Talk to discuss his article, coauthored with Dr George Maliha, Keith Robert Thomas, and Mary Ellen Nepps: “When Should Patients At the End-of-Life Get Antimicrobials?”  Recorded March 14, 2024.  Read the full article for free at JournalOfEthics.org

On this episode of The ICHE Podcast, Editor-in-Chief, David Calfee, MD, MS is joined by Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, Jasmine R. Marcelin, MD, FACP, FIDSA, and Caitlin McGrath, MD, MS. Today's episode explores DEI in infection prevention and antimicrobial stewardship as our guests discuss their recent articles in ICHE and highlight ICHE's dedicated section on DEI. Listen as our guests discuss various health equity concepts and associated terminology, how they apply to HAI risk and AMR risk, important areas of focus for future research, and what we can do today to help mitigate current disparities and inequities. After listening, be sure to visit cambridge.org/iche to read the full articles featured in today's episode.

This is Ep. 2 of SHEA's two-part series, Impact of Blood Culture Practices on Antibiotic Stewardship & HAI Surveillance & Management. This episode focuses on the controversy surrounding follow-up blood cultures after initial bacteremia episodes. The frequency of obtaining blood cultures and their role in scenarios like leukocytosis and fevers will be explored. Speakers: Joshua Thaden, MD, PhD Rachel Wattier, MD, MHS Moderator: Hana Winders, PharmD, BCIDP

This is Ep. 1 of SHEA's two-part series, Impact of Blood Culture Practices on Antibiotic Stewardship & HAI Surveillance & Management. Speakers discuss effective preventive measures for reducing healthcare-onset bacteremia rates. Speakers: Mark Rupp, MD Anna Sick-Samuels, MD, MPH Moderator: Patricia Pichilingue-Reto, MD, FAAP, AAHIVS

Show notes at pharmacyjoe.com/episode909. In this episode, I’ll discuss a novel metric for antibiotic stewardship. The post 909: Is this a better metric for antibiotic stewardship? appeared first on Pharmacy Joe.

Show notes at pharmacyjoe.com/episode909. In this episode, I’ll discuss a novel metric for antibiotic stewardship. The post 909: Is this a better metric for antibiotic stewardship? appeared first on Pharmacy Joe.

In this episode, Dr. David Kaufman discusses his interest in pediatrics and infectious disease, particularly in the prevention and treatment of neonatal infections. He highlights the challenges of antibiotic use in the NICU and the interplay between probiotics, prebiotics, antibiotics, and infections. Dr. Kaufman emphasizes the need for better quality control and standardization of probiotics, as well as the importance of consent and shared decision-making in their use. He also discusses the potential benefits of lactoferrin in reducing necrotizing enterocolitis (NEC) and the future directions in infection management. The episode concludes with a discussion of the Neonatal Antibiotic Stewardship web app. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This is Ep. 2 of SHEA's two-part series, Infection Prevention & Antibiotic Stewardship at End of Life. This episode explores the role of antibiotic treatment in the end-of-life setting with a focus on balancing the role in maintaining comfort and relieving symptoms with the concern for adverse effects, excessive or futile use, and contribution to the development of antibiotic resistance. Speakers: Jon P. Furuno, PhD Susan L. Mitchell, MD, MPH Moderator: Haley Pritchard, MD, MS

Highlights of the JAANP issue topics: Antibiotic Stewardship, Transgender Healthcare, Diabetes, Hyperlipidemia, Persons with Disabilities, microcurrent neurofeedback,

This is Ep. 1 of SHEA's two-part series, Infection Prevention & Antibiotic Stewardship at End of Life. This episode focuses on the risks and benefits of IP policies in the acute care setting - such as isolation requirements and visitor restrictions - and how they might (or might not) be adapted at end-of-life. Speakers: Rupak Datta, MD, MPH, PhD Melissa Wachterman, MD, MSc, MPH Moderator: Lindsey Gottlieb, MD

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Kelsey L. Jensen, Pharm.D., R.Ph. Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD The appropriate use of antibiotics is important for a variety of reasons. It helps keep our patients safe, helps maintain antibiotic effectiveness in treating bacterial infections, and helps control the cost of patient care. Very few new antibiotics have been introduced in the past few decades. Because of this, as well as the accelerated emergence of antibiotic resistance, it's more important than ever that we practice careful and responsible use of antibiotics. Antibiotic stewardship is the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients. This podcast will focus on out-patient antibiotic stewardship and my guests include Kelsey L. Jensen, Pharm.D., R.Ph., and Daniel Ilges, Pharm.D., R.Ph., BCIPD, both pharmacists at the Mayo Clinic. We'll discuss how antibiotics are often prescribed incorrectly, the barriers we face as clinicians in prescribing antibiotics and how we can all improve our antibiotic stewardship. Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

In this final episode of SHEA's podcast series, Social & Cultural Aspects of Infection Control & Antibiotic Stewardship, speakers discuss some of the barriers that contribute to the decreased adherence to infection prevention guidelines and the implications they have with regard to patient safety, in addition to potential behavioral strategies that can be implemented to drive appropriate infection prevention practices. Speakers: Jennifer Hanrahan, DO Daniel Walker, PhD, MPH Moderator: Catherine Derber, MD, FACP, FIDSA

Anti-Microbial Stewardship Programs are critical to optimizing utilization, mitigating resistance, and improving patient outcomes. These programs are continuously refined, and recent updates to The Joint Commission standards provide an opportunity to enhance our approach. Dr. Ripal Jariwala, Infectious Diseases Clinical Pharmacist, and Assistant Clinical Professor at the University of California San Francisco, and Dr. Ethan A. Smith, Clinical Infectious Diseases Specialist at Ronald Reagan UCLA Medical Center, join host Gretchen Brummel to discuss the revised standards and implications for pharmacy.   Guest speakers:  Dr. Ripal Jariwala, PharmD, BCIDP, AAHIVP Infectious Diseases Clinical Pharmacist, and Assistant Clinical Professor UCSF    Dr. Ethan A. Smith, PharmD., BCIDP Clinical Infectious Diseases Specialist Ronald Reagan UCLA Medical Center   Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence   Show Notes:  [01:01-01:47] The guests background  [01:48-02:58] Brief update of the recent changes to Antimicrobrial Stewardship [02:59-07:35] Interpreting the new EP-10 Joint Commission standard about financial and IT resources [07:36-11:23] The current landscape on FTEs to support antimicrobial stewardship [11:24-15:13] EP15 on evidence-based use of antibiotics considerations [15:14-18:27] How do you approach meeting the revised standard on data collection analysis and recording for EP20 [18:28 -21:23] Other standards besides the joint commission standards that people need to be aware of [21:24-23:34] Other related work going on in this space [23:35-26:54] More information or other resources to find those items about antimicrobial stewardship   Links | Resources: Knowledge on the Go Podcast: Updates for Antimicrobial Stewardship Standards VHA directive 1031: Click here CDC Updates on Antibiotic Stewardship and Required Antimicrobial Use and Resistance Reporting – On Demand: CDC Updates OnDemand2023 document and Click here to play recording   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Spotify Android RSS Feed

This is Ep. 1, Part 1 of SHEA's podcast series, Social & Cultural Aspects of Infection Control & Antibiotic Stewardship. This episode focuses on the key drivers of suboptimal prescribing and how they may differ within various specialties within hospitals. In addition, speakers will discuss how to determine what behavioral domains are influencing inappropriate antibiotic prescribing which is important for determining which interventions can be useful to implement. Speakers: Esmita Charani, PhD, MsC, MPharm, MRPSGB David Schwartz, MD Brad Spellberg, MD Moderator: Hana R. Winders, PharmD, BCIDP

Dr. Jerome Adams, former United States Surgeon General, says businesses learned from the pandemic that public health is a worthy investment; Destani Bizune, an Epidemiologist in the Office of Antibiotic Stewardship at the CDC, discusses the CDC's guidance for public health agencies based on its Core Elements of Antibiotic Stewardship framework; Vanessa Iheanachor, a Health Communication Specialist at the CDC, tells us health inequities are another concern to address; and Cara Biddlecom is now the Interim Public Health Director at the Oregon Health Authority's Public Health Division. CNN News Article: The US has a mental health crisis that could undermine our democracy, US surgeons general say CDC Webpage: Core Elements of Antibiotic Stewardship for Health Departments CDC Webpage: About U.S. Antibiotic Awareness Week (USAAW) ASTHO Webpage: Cara Biddlecom, MPH

CDC recently released the Core Elements of Antibiotic Stewardship for Health Departments to outline the structure and activities of state and local health department antibiotic stewardship programs. The podcast will highlight opportunities for pharmacists to partner with state and local health departments to optimize antibiotic use in their communities.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Dr. Jeff Linder, Chief of the Division of General Internal Medicine at Northwestern University Feinberg School of Medicine, discusses how technology and telehealth can be used to reduce overprescribing of antibiotics.

In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can't miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today's episode we are sitting down with Dr. Arjun Srinivasan and learning more about his session, New CDC Requirements for Antibiotic Use Reporting and Opportunities for Antibiotic Stewardship. If you haven't already, register for the Midyear clinical meeting today at midyear.ashp.org. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Show notes at pharmacyjoe.com/episode842. In this episode, I'll discuss opportunities for antibiotic stewardship before hospital discharge. The post 842: Antibiotic Stewardship Before Discharge? appeared first on Pharmacy Joe.

Show notes at pharmacyjoe.com/episode842. In this episode, I ll discuss opportunities for antibiotic stewardship before hospital discharge. The post 842: Antibiotic Stewardship Before Discharge? appeared first on Pharmacy Joe.

This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.   Show notes: R3 Report Antibiotic Stewardship: https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf The Joint Commission Antibiotic Stewardship Resources: https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Dr. Deborah Milito:  linkedin.com/in/deborah-milito-32a28156   Dr. Scott Stewart:  linkedin.com/in/scott-stewart-34973870   Dr. Tamara Ruggles:  linkedin.com/in/tamara-ruggles-491882251   CDC Core Elements of Antibiotic Stewardship for Nursing Homes:  https://www.cdc.gov/antibiotic-use/core-elements/nursing-homes.html   ASCP Antimicrobial Stewardship Toolkit:  https://www.med-pass.com/antimicrobial-stewardship-toolkit-for-long-term-care-with-usb-flash-drive.html     FDA Advisory Committee Calendar:  https://www.fda.gov/advisory-committees/advisory-committee-calendar       ACIP meeting information:  https://www.cdc.gov/vaccines/acip/meetings/index.html   Candida auris:  https://www.fda.gov/media/141083/download   Updated guidelines for Asymptomatic Bacteriuria:  https://www.idsociety.org/practice-guideline/asymptomatic-bacteriuria/   Clostridiodes difficile clinical practice guidelines:  https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/   Community-Aquired Pneumonia guidelines:  https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST?role=tab       Please e-mail questions, comments, and funny pharmacy jokes to ltcpharmacypodcast@gmail.com.  We would love to hear from you!

In today's VETgirl podcast, we interview Dr. Michael Lappin, PhD, DACVIM, Kenneth W. Smith Professor of Small Animal Clinical Veterinary Medicine and Director at the Center for Companion Animal Studies at Colorado State University, on all things probiotics in dogs and cats. Learn about the importance of antibiotic stewardship and the role of probiotics in veterinary medicine. While veterinarians should do their best to avoid unnecessary use of antibiotics, in remains that these medications play a vital role in the management of pets with a variety of infectious conditions. Tune in to learn some of of the studies Dr. Lappin has conducted on both dogs and cats using probiotics to mitigate the negative effects of antibiotic use, and how long probiotics should be given as part of an adjunct therapy with antibiotics. Tune it in this VETgirl podcast to learn more!

Episode Notes Drs. Zack Nelson (@zacroBID), Alison Dittmer, and Michael Pulia (@DrMichaelPulia) join Dr. Jillian Hayes (@thejillianhayes) to discuss the ins and outs of antimicrobial stewardship in one of the busiest parts of the hospital: the emergency department! Tune in for a discussion on communication considerations in the ED, the role of lipoglycopeptides for common gram-positive syndromes, and a rapid-fire round discussing common stewardship interventions. This podcast was supported by an educational grant from Melinta Therapeutics. References: Pulia M, et al. Antimicrobial Stewardship in the Emergency Department. Emerg Med Clin N Am 2018;36(4):853-872. doi: 10.1016/j.emc.2018.06.012. PMID: 30297009. Rech, Megan A et al. “PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.” Critical Care Explorations 2021;3(4):e0406. doi:10.1097/CCE.0000000000000406. PMID: 33912836. Sacdal JPA, Cheon E et al. Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department. Am J Emerg Med 2022;60:223-224. Jenkins TC, Jaukoos JS et al. Patterns of use and perceptions of an institution-specific antibiotic stewardship application among emergency department and urgent care clinicians. Infection Control and Hospital Epidemiology 2020;41:212-215. Dretske D, Schulz L, Werner E, Sharp B, Pulia M. Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series. The American Journal of Emergency Medicine 2021;43:77-80. doi: 10.1016/j.ajem.2021.01.050. PMID: 33545550. Paul M, Pulia M, Pulcini C. Antibiotic stewardship in the emergency department: not to be overlooked. Clin Microbiol Infect 2021;27(2):172-174. doi: 10.1016/j.cmi.2020.11.015. PMID: 33253938. Baxa J, McCreary E, Schulz L, Pulia M. Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department. Am J Emerg Med. 2020;38(2):321-324. doi:10.1016/j.ajem.2019.158442. Pulia MS, Hesse S, Schwei RJ, Schulz LT, Sethi A, Hamedani A. Inappropriate Antibiotic Prescribing for Respiratory Conditions Does Not Improve Press Ganey® Patient Satisfaction Scores in the Emergency Department. Open Forum Infect Dis 2020;7(6): ofaa214. doi:10.1093/ofid/ofaa214. Pulia MS, Lindenauer PK. Annals for Hospitalists Inpatient Notes - A Critical Look at Procalcitonin Testing in Pneumonia. Ann Intern Med. 2021;174(6):HO2-HO3. doi:10.7326/M21-1913. Redwood R, Knobloch MJ, Pellegrini DC, Ziegler MJ, Pulia M, Safdar N. Reducing unnecessary culturing: a systems approach to evaluating urine culture ordering and collection practices among nurses in two acute care settings. Antimicrob Resist Infect Control. 2018;7. doi:10.1186/s13756-017-0278-9. Pulia MS, Schwei RJ, Hesse SP, Werner NE. Characterizing barriers to antibiotic stewardship for skin and soft-tissue infections in the emergency department using a systems engineering framework. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e180. doi:10.1017/ash.2022.316. May L, Gudger G, Armstrong P, et al. Multisite exploration of clinical decision making for antibiotic use by emergency medicine providers using quantitative and qualitative methods. Infect Control Hosp Epidemiol. 2014;35(9):1114-1125. doi:10.1086/677637. May L, Cosgrove S, L'archeveque M, et al. A Call to Action for Antimicrobial Stewardship in the Emergency Department: Approaches and Strategies. Ann Emerg Med 2013;62(1):69-77.e2. doi: 10.1016/j.annemergmed.2012.09.002. PMID: 23122955. Schoffelen T, Schouten JA, Hoogerwerf JJ, et al. Quality indicators for appropriate antimicrobial therapy in the emergency department: a pragmatic Delphi procedure. Clin Microbiol Infect 2021;27(2):210-214. doi: 10.1016/j.cmi.2020.10.027. PMID: 33144204. Yadav K, Stahmer A, Mistry RD, May L. An Implementation Science Approach to Antibiotic Stewardship in Emergency Departments and Urgent Care Centers. Academic Emergency Medicine 2020; 27(1):31-42. doi: 10.1111/acem.13873. PMID: 31625653. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/   SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: https://sidp.org/Become-a-Member Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/ Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.

The post Episode 101. Aspiration Pneumonia: Antibiotic Stewardship and Evidence-Based Treatment Strategies appeared first on The Pharm So Hard Podcast.

With the conclusion of PEM23, a fantastic pediatric emergency medicine conference, we interview Dr. Chris Amato regarding antibiotic stewardship and how sometimes more is NOT in fact better. Leadership and Advocacy 2023 Registration - www.acep.org/LAC

How do we, as doctors, prescribe antibiotics responsibly? Dr. Mackenzie Keintz, an Infectious Disease Fellow with the University of Nebraska chats with Dr. Block about antibiotics, antibiotic stewardship, when to prescribe them, what does antibiotic resistance really means, and how to avoid it. Dr Mackenzie Keintz graduated from the University of Wisconsin-Madison, majoring in Medical Microbiology and Immunology and Biology. She attended medical school at St. George's University, and completed her residency at the University of Nebraska Medical Center. Dr Keintz's Twiter: https://twitter.com/MKeintzMD   This episode is sponsored by Locumstory. For more information on Locumstory, go to https://locumstory.com/   The ideas expressed on this podcast are those of the interviewer and interviewee and do not represent those of their respective employers. Those on this podcast accept no liability for the outcomes of medical decisions based on this information. As the radiologists like to say "clinical correlation is required". This is not medical advice and this does not constitute a physician-patient relationship. If you have a medical problem, seek medical attention.  

Pharmacy-led programs are critical to improving chronic conditions, reducing unnecessary utilization and lowering the total cost of care—all while keeping patient goals top of mind. Join us in the miniVHAN as we discuss the importance of antibiotic stewardship, practical ideas for developing a program in your organization, and key clinical and patient engagement opportunities to consider. Have ideas to share or want to be a guest on the miniVHAN podcast? Contact us anytime at minivhanpodcast@vhan.com. Guests this episode: Montgomery Green, PharmD, Clinical Pharmacist and Vaccines Medical Science Liaison at GSK | Danny Truelove, PharmD, BCPS, BCACP, AAHIVP, Director of Pharmacy for University Health Network at University of Tennessee Medical Center | Jacky Bradley, PharmD, MBA, Clinical pharmacist, Vanderbilt Health Affiliated Network